Dithranol (anthralin) in psoriasis. The effect on DNA synthesis, granular layer and parakeratosis.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001345:Autoradiography; D001706:Biopsy; D002452:Cell Count; D004247:DNA / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D007642:Keratosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010241:Parakeratosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000873:Anthracenes; D014316:Tritium; D004247:DNA; D013936:Thymidine